Effects of estrogen and prolactin on thymidine kinase isozyme activities in DMBA-induced rat mammary tumor. 1984

S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto

Effects of prolactin or estrogen on the activity of the pyrimidine salvage pathway enzyme thymidine kinase (TK) in 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary tumors were investigated in ovariectomized rats. Prolactin induced by perphenazine administration significantly enhanced the activities of total TK or its isozyme in the tumors. This specific TK isozyme separated by DEAE-cellulose column chromatography was suggested to be involved in DNA synthesis because it was not affected by dCTP. Its Mr was estimated to be approx. 100 000 by high-performance liquid chromatography. In contrast, estrogen alone did not raise the activity of the specific TK isozyme in the tumors.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D010546 Perphenazine An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE. Chlorpiprazine,Perfenazine,Trilafon
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002848 Chromatography, DEAE-Cellulose A type of ion exchange chromatography using diethylaminoethyl cellulose (DEAE-CELLULOSE) as a positively charged resin. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) DEAE-Cellulose Chromatography,Chromatography, DEAE Cellulose,DEAE Cellulose Chromatography
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003845 Deoxycytosine Nucleotides Cytosine nucleotides which contain deoxyribose as the sugar moiety. Deoxycytidine Phosphates,Nucleotides, Deoxycytosine,Phosphates, Deoxycytidine
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen

Related Publications

S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
February 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
December 1990, The American journal of pathology,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
December 1984, Nihon Gan Chiryo Gakkai shi,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
January 1977, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
November 1971, Cancer,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
September 1984, Biochemical and biophysical research communications,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
February 2006, Cell biology international,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
January 1977, Oncology,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
June 1988, Nihon Geka Gakkai zasshi,
S Sakamoto, and T Kawasaki, and H Yoshino, and H Kudo, and R Okamoto
January 1993, Clinical therapeutics,
Copied contents to your clipboard!